| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.81B | 126.95B | 114.85B | 91.33B | 84.78B | 82.25B |
| Gross Profit | 56.07B | 51.41B | 41.20B | 33.09B | 30.52B | 29.74B |
| EBITDA | 18.98B | 16.92B | 10.06B | 4.70B | 5.82B | 7.00B |
| Net Income | 16.58B | 11.46B | 6.24B | 1.35B | 2.81B | 3.95B |
Balance Sheet | ||||||
| Total Assets | 127.32B | 123.52B | 114.41B | 106.40B | 85.97B | 82.25B |
| Cash, Cash Equivalents and Short-Term Investments | 17.34B | 16.11B | 11.79B | 15.38B | 14.35B | 15.30B |
| Total Debt | 16.16B | 20.45B | 18.45B | 20.58B | 10.37B | 10.68B |
| Total Liabilities | 46.99B | 50.90B | 52.97B | 53.89B | 38.09B | 36.55B |
| Stockholders Equity | 79.86B | 72.19B | 61.04B | 52.11B | 47.88B | 45.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.30B | 1.03B | -8.11B | 3.06B | 5.97B |
| Operating Cash Flow | 0.00 | 10.82B | 2.71B | -6.49B | 6.19B | 8.51B |
| Investing Cash Flow | 0.00 | -4.59B | -3.59B | -3.03B | -4.39B | -4.55B |
| Financing Cash Flow | 0.00 | -2.70B | -3.56B | 8.26B | -3.52B | -850.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥60.20B | 9.58 | ― | 1.12% | 14.84% | 7.57% | |
80 Outperform | ¥45.97B | 7.34 | ― | 3.21% | 7.99% | 50.13% | |
79 Outperform | ¥52.16B | 10.04 | ― | 1.94% | -4.17% | -7.07% | |
76 Outperform | ¥204.08B | 22.19 | ― | 1.88% | 6.56% | 106.55% | |
75 Outperform | ¥34.15B | 13.64 | ― | 2.29% | 6.81% | 12.70% | |
74 Outperform | ¥73.66B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |